What is Lisata Therapeutics Inc. (LSTA) stock price today?

Lisata Therapeutics Inc. (LSTA) currently trades at $3.12 per share. The stock has a market capitalization of $28.18M and a P/E ratio of —x.

Is LSTA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Lisata Therapeutics Inc. has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Lisata Therapeutics Inc.'s revenue and earnings?

Lisata Therapeutics Inc. has trailing twelve-month (TTM) revenue of $170000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.91.

LSTA

Lisata Therapeutics Inc.

NASDAQ: LSTA · HEALTHCARE · BIOTECHNOLOGY

$3.12

-3.11% today

Updated 2026-04-30

Market cap

$28.18M

P/E ratio

—

P/S ratio

165.77x

EPS (TTM)

$-1.91

Dividend yield

—

52W range

$2 – $5

Volume

0.1M

Market cap

$28.18M

P/E ratio

—

P/S ratio

165.77x

EPS (TTM)

$-1.91

Dividend yield

—

52W range

$2 – $5

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

4.0

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$9.50

+204.49%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.25M

- Revenue declining -90.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$121.37M	$0.00	$1.00M	$170000.00	$170000.00
Net income	$-54.23M	$-20.84M	$-19.98M	$-16.59M	$-2.95M
EPS	—	—	—	—	$-1.91
Free cash flow	$-21.45M	$-20.03M	$-19.36M	$-15.98M	$-3.25M
Profit margin	-44.68%	—	-1,998.50%	-9,756.47%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LSTA	$28.18M	22	2.7	2.5	4.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Lisata Therapeutics Inc. trades at $3.12. Our Smart Value Score of 22/100 indicates the stock is weak. TTM revenue stands at $170000.00.

Frequently asked questions

What is Lisata Therapeutics Inc.'s stock price?

Lisata Therapeutics Inc. (LSTA) trades at $3.12.

Is Lisata Therapeutics Inc. overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of Lisata Therapeutics Inc. (LSTA)?

The analyst target price is $9.50, representing +204.5% upside from the current price of $3.12.

What is Lisata Therapeutics Inc.'s revenue?

TTM revenue is $170000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio165.77x

ROE-75.50%

Beta1.11

50D MA$4.51

200D MA$3.05

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LSTA vs LLY →LSTA vs JNJ →LSTA vs ABBV →Stock screener →